Xenetic Biosciences announces 1-for-10 reverse stock split effective May 15, 2023

Xenetic Biosciences, Inc.

Reverse split reduces outstanding shares from 15,166,596 to ~1,516,660; authorized shares from 100M to 10M.
Effective 12:01 a.m. ET on May 15, 2023; no fractional shares – any fraction rounded up.
Common stock continues trading on Nasdaq under symbol XBIO with new CUSIP 984015602.
Warrants (XBIOW) and equity awards proportionately adjusted; no action required by holders.
Press release issued May 12, 2023; Certificate of Change filed with Nevada Secretary of State.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Xenetic Biosciences, Inc.: Filed a Certificate of Change to effect a one-for-ten reverse stock split, reducing authorized common stock from 100,000,000 to 10,000,000 shares (effective 2023-05-11).

Change: charter amendment
Effective: 2023-05-11

Exact text from the filing

on May 11, 2023, Xenetic Biosciences, Inc. (the “Company”) filed a Certificate of Change to the Company’s Articles of Incorporation (the “Change”) with the Secretary of State of the State of Nevada to effect a one-for-ten reverse stock split of its authorized, issued and outstanding common stock

View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

Xenetic Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-003243

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.